“If you look what Congress has done every single year, the past several years, whenever they pass their annual budget they have a proviso in that budget with the appropriation to the Department of Justice saying none of the money that we’re appropriating to you, Department of Justice, can be used to challenge or attack or undermine laws in states that have authorized the medical use of cannabis,” he says. “So, you’ve got Congress every year saying to the states this is something that’s okay for you to do. You’ve also seen that in the Executive Branch and the Department of Justice. There are written directives to U.S. attorneys throughout the country saying, ‘Do not challenge states that have passed medical cannabis laws.’ And finally, you have the courts, the Judicial Branch, which has repeatedly held that authorizing it for medicinal use is within a state’s power.”
The informative cannabis social network. Join groups, make friends and be part of the cannabis community! Share your recipes, product & strain reviews, tutorials and more! Log in or register to continue
- Loading stock data...
- Etain’s Premium Cannabis Products Now Available at The Travel Agency, at Union Square
- Puffco Launches New Limited-Edition Flourish Collection, Along with its First Direct-to-Consumer Flourish Glass Marketplace
- IGC Pharma Announces Equity Analyst Coverage by Ascendiant with a “Buy” Recommendation and $3.00 Price Target
- PESG Industry Updates: Germany’s Cannabis Act and Its Impact on the Medical Cannabis Landscape
- The Cannabist Company Highlights Product Innovation with Launch of Unique Fast-Acting and Longer-Lasting Layered Edibles